AIM IMMUNOTECH INC. Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2012-01-31)
AIM IMMUNOTECH INC. (AIM) reported Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2012-01-31) of -$896.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax · last filed 2012-03-14
- AIM IMMUNOTECH INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, net of tax (deprecated 2012-01-31) for fiscal 2011 was -$896.00K.
- AIM IMMUNOTECH INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, net of tax (deprecated 2012-01-31) for fiscal 2010 was -$39.00K.
- AIM IMMUNOTECH INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, net of tax (deprecated 2012-01-31) for fiscal 2009 was $0.00.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2012-01-31) 12 month |
|---|---|
| 2011-12-31 | -$896.00K 10-K · filed 2012-03-14 |
| 2010-12-31 | -$39.00K 10-K · filed 2012-03-14 |
| 2009-12-31 | $0.00 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |